Diabetes Detection and Prevention in Dermatology

We are currently in the midst of an international epidemic of diabetes mellitus (DM) and prediabetes. The prevalence of DM in the United States is estimated at 9.4% of the population across all ages, while an estimated 1 in 3 Americans (33.9%) has prediabetes. According to the WHO, about 60 million...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandra Ngo (Author), Luise Froessl (Author), John Wesley McWhorter (Author), William Brett Perkison (Author), Rajani Katta (Author)
Format: Book
Published: Mattioli1885, 2021-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_918a7b58fc644450b98ff38c6fcc89e4
042 |a dc 
100 1 0 |a Alexandra Ngo  |e author 
700 1 0 |a Luise Froessl  |e author 
700 1 0 |a John Wesley McWhorter  |e author 
700 1 0 |a William Brett Perkison  |e author 
700 1 0 |a Rajani Katta  |e author 
245 0 0 |a Diabetes Detection and Prevention in Dermatology 
260 |b Mattioli1885,   |c 2021-09-01T00:00:00Z. 
500 |a 10.5826/dpc.1104a131 
500 |a 2160-9381 
520 |a We are currently in the midst of an international epidemic of diabetes mellitus (DM) and prediabetes. The prevalence of DM in the United States is estimated at 9.4% of the population across all ages, while an estimated 1 in 3 Americans (33.9%) has prediabetes. According to the WHO, about 60 million people suffer from diabetes in the European Region. Dermatologists may play an important role in tackling this epidemic via efforts to improve early detection of both diabetes and prediabetes. Dermatologists often treat patients with, or at risk of, diabetes. This includes patients who present with cutaneous manifestations such as acanthosis nigricans, as well as patient populations at increased risk, including those with psoriasis, hidradenitis suppurativa, and polycystic ovarian syndrome. Simple screening guidelines can be used to identify patients at risk, and screening can be performed via a single non-fasting blood test. The diagnosis of prediabetes is a key feature in diabetes prevention, as interventions in this group can markedly reduce progression towards diabetes. In addition to referral to a primary care physician, dermatologists may refer these patients directly to structured behavioral lifestyle intervention programs known as diabetes prevention programs. A significant portion of the population lacks routine care by a primary care physician, and current data indicates need for improvement in diabetes screening and prevention among patient groups such as those with psoriasis. These factors highlight the importance of the dermatologist's role in the detection and prevention of diabetes. 
546 |a EN 
690 |a diabetes prevention 
690 |a diabetes in dermatology 
690 |a diabetes skin findings 
690 |a psoriasis and diabetes 
690 |a diabetes screening 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatology Practical & Conceptual (2021) 
787 0 |n https://dpcj.org/index.php/dpc/article/view/1703 
787 0 |n https://doaj.org/toc/2160-9381 
856 4 1 |u https://doaj.org/article/918a7b58fc644450b98ff38c6fcc89e4  |z Connect to this object online.